msc-afp
Cell therapyexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2013 (NCT01915927)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- msc-afp
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03449069 | Phase 1 | Jul 23, 2018 | Mayo Clinic |
| NCT03220243 | Phase 1 | Oct 19, 2017 | Mayo Clinic |
| NCT03209700 | Phase 1 | Jul 20, 2017 | Mayo Clinic |
| NCT02589119 | Phase 1 | Jan 1, 2016 | Mayo Clinic |
| NCT01915927 | Phase 1 | Jul 1, 2013 | Mayo Clinic |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mayo Clinic | Academic/Hospital | 5 | 5 | 1 | 2013 |
1 organizations
Page 1 / 1